Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Alirocumab vs usual lipid-lowering care as add?on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial
- Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: Results from the ESPOIR cohort
- Trifluridine/tipiracil (TAS-102) in refractory metastatic colorectal cancer: A multicenter register in the frame of the Italian compassionate use program
- Survival outcomes for advanced kidney cancer patients in the era of targeted therapies
- Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
PHARMACOLOGY
- Clinical acceptability of trimetazidine modified-release 80 mg once daily vs trimetazidine modified-release 35 mg twice daily in stable angina pectoris
- Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia
- Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis
- Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia
- Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure
CLINICAL PHARMACOLOGY
- Conservative management following clinical complete response to neoadjuvant chemotherapy for muscle-invasive bladder cancer: Contemporary outcomes of a multi-institutional cohort study
- The potential of narrow band uvb to induce sustained durable complete remission off-therapy in stage I mycosis fungoides
- Trends in the clinical presentation, treatment, and survival for pancreatic adenocarcinoma
- Application of Cu-64 NODAGA-PSMA PET in prostate cancer
- Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
ONCOLOGY
